PRCT Earnings & Financial Statements
PROCEPT BioRobotics Corporation
$17.90
-$0.01(-0.06%)
46
Overall
55
Value
18
Tech
65
Quality
Market Cap
$1.03B
Volume
1.18M
52W Range
$16.67 - $38.11
Target Price
$21.64
PRCT earnings and financial statements: PROCEPT BioRobotics Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
PRCT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $308.05M | $224.50M | $136.19M | $75.01M | $34.47M |
| Cost of revenue | $111.83M | $87.40M | $65.14M | $37.93M | $18.61M |
| Operating income | -$103.86M | -$96.61M | -$109.17M | -$80.72M | -$54.16M |
| EBITDA | -$85.41M | -$81.63M | -$98.09M | -$81.97M | -$50.84M |
| Net income | -$95.57M | -$91.41M | -$105.90M | -$87.15M | -$59.85M |
| EPS (diluted) | $-1.72 | $-1.75 | $-2.24 | $-1.96 | $-3.63 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $508.08M | $534.02M | $404.72M | $309.33M | $337.02M |
| Total liabilities | $142.21M | $131.80M | $123.97M | $112.26M | $69.93M |
| Shareholders’ equity | $365.87M | $402.22M | $280.75M | $197.07M | $267.09M |
| Cash and equivalents | $286.50M | $333.73M | $257.22M | $221.86M | $304.30M |
| Long-term debt | $76.27M | $78.34M | $77.52M | $75.19M | $51.99M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$48.98M | -$99.21M | -$108.00M | -$80.38M | -$57.33M |
| Capital expenditure | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592.0K |
| Free cash flow | -$58.34M | -$103.62M | -$133.21M | -$83.03M | -$57.93M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRCT | $17.90 | -0.1% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PROCEPT BioRobotics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW